Mike Braun actually said...

We should be that leading edge and we should have a system that accommodates it.

The Promising Pathway Act is a commonsense step to give the FDA the flexibility it needs to serve Americans with these most trying diseases.

My simple answer is that ALS patients are willing to accept greater risk because we know what is behind door number two.

My simple answer is that ALS patients are willing to accept greater risk because we know what is behind door number two.